Prediction of mortality in acute pulmonary embolism in cancer-associated thrombosis (MAUPE-C): derivation and validation of a multivariable model
- 14 March 2024
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 57 (4) , 668-676
Abstract
Optimal risk stratification of patients with cancer and pulmonary embolism (PE) remains unclear. We constructed a clinical prediction rule (CPR) named ‘MAUPE-C’ to identify patients with low 30 days mortality. The study retrospectively developed and internally validated a CPR for 30 days mortality in a cohort of patients with cancer and PE (both suspected and unsuspected). Candidate variables were chosen based on the EPIPHANY study, which categorized patients into 3 groups based on symptoms, signs, suspicion and patient setting at PE diagnosis. The performance of ‘MAUPE-C’ was compared to RIETE and sPESI scores. Univariate analysis confirmed that the presence of symptoms, signs, suspicion and inpatient diagnosis were associated with 30 days mortality. Multivariable logistic regression analysis led to the exclusion of symptoms as predictive variable. ‘MAUPE-C’ was developed by assigning weights to risk factors related to the β coefficient, yielding a score range of 0 to 4.5. After receiver operating characteristic (ROC) curve analysis, a cutoff point was established at ≤ 1. Prognostic accuracy was good with an area under the curve (AUC) of 0.77 (95% CI 0.71–0.82), outperforming RIETE and sPESI scores in this cohort (AUC of 0.64 [95% CI 0.57–0.71] and 0.57 [95% CI 0.49–0.65], respectively). Forty-five per cent of patients were classified as low risk and experienced a 2.79% 30 days mortality. MAUPE-C has good prognostic accuracy in identifying patients at low risk of 30 days mortality. This CPR could help physicians select patients for early discharge.Keywords
This publication has 32 references indexed in Scilit:
- Risk stratification for clinical severity of pulmonary embolism in patients with cancer: a narrative review and MASCC clinical guidance for daily careSupportive Care in Cancer, 2022
- Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active CancerChest, 2020
- Outpatient management of incidental pulmonary embolism in cancer patientClinical and Translational Oncology, 2019
- Antithrombotic Therapy for VTE DiseaseChest, 2016
- Applied Logistic Regression2013
- Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary EmbolismArchives of internal medicine (1960), 2010
- Incidental venous thromboembolism in cancer patients: prevalence and consequenceThrombosis Research, 2010
- Clinical Prediction Models2009
- The Elements of Statistical Learning2009
- Presentation of multivariate data for clinical use: The Framingham Study risk score functionsStatistics in Medicine, 2004